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Abstract
Background: Health effects of pesticides are easily diagnosed when acute poisonings occurs, nevertheless,
consequences from chronic exposure can only be observed when neuropsychiatric, neurodegenerative or
oncologic pathologies appear. Therefore, early monitoring of this type of exposure is especially relevant to avoid
the consequences of pathologies previously described; especially concerning workers exposed to pesticides on
the job. For acute organophosphate pesticides (OPP) exposure, two biomarkers have been validated: plasma
cholinesterase (ChE) and acetylcholinesterase (AChE) from erythrocytes. These enzymes become inhibited when
people are exposed to high doses of organophosphate pesticides, along with clear signs and symptoms of
acute poisoning; therefore, they do not serve to identify risk from chronic exposure. This study aims to assess a
novel biomarker that could reflect neuropsychological deterioration associated with long-term exposure to
organophosphate pesticides via the enzyme acylpeptide-hydrolase (ACPH), which has been recently identified as
a direct target of action for some organophosphate compounds.
Methods/Design: Three population groups were recruited during three years (2011–2013): Group I having no
exposure to pesticides, which included people living in Chilean coastal areas far from farms (external control);
Group II included those individuals living within the rural and farming area (internal control) but not occupationally
exposed to pesticides; and Group III living in rural areas, employed in agricultural labour and having had direct
contact with pesticides for more than five years. Blood samples to assess biomarkers were taken and neuropsychological
evaluations carried out seasonally; in three time frames for the occupationally exposed group (before, during and after
fumigation period); in two time frames for internal control group (before and during fumigation), and only once for the
external controls. Neuropsychological evaluations considered cognitive functions, affectivity and psychomotor activity.
The biomarkers measured included ChE, AChE and ACPH. Statistical analysis and mathematical modelling used both
laboratory results and neuropsychological testing outcomes in order to assess whether ACPH would be acceptable as
biomarker for chronic exposure to OPP.
Discussion: This study protocol has been implemented successfully during the time frames mentioned above for
seasons 2011, 2012 and 2013–2014.
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Background
Human exposure to organophosphate pesticides (OPP)
have been extensively documented showing health prob-
lems, associated primarily with agricultural workers hav-
ing occupational exposure in developing countries [1].
While acute poisonings are relatively easy to diagnose
because they are accompanied with symptoms of cholin-
ergic overstimulation [2], the effects of chronic, long-
term exposure to low OPP doses only become evident
when carcinogenic, teratogenic [3,4] or neurodegenera-
tive pathologies appear [5-7]. The nervous system is par-
ticularly sensitive to the effects of OPP, therefore early
bio-monitoring of neurotoxic effects in exposed people
can prevent the onset of future neurodegenerative dis-
eases by taking some measures to avoid or diminish the
level of OPP exposure.
The diagnosis of acute or chronic exposure to organo-
phosphate pesticides (OPP) usually employs two different
blood enzymes as biomarkers; plasma pseudocholinester-
ase (or butyrylcholinesterase, BuChE) and erythrocyte
acetylcholinesterase (AChE), the later being the enzyme
most used for estimating chronic exposure [8]. The cata-
lytic activity of both these enzymes is inhibited by OPP
and in the case of AChE inhibition, where the enzyme is
expressed in the synapses of the nervous system, this in-
hibition reflects cholinergic overstimulation responsible
for the signs and symptoms of OPP poisoning. Therefore,
their usefulness as biomarkers of low-dose exposure to
OPP is limited. Because of this, it is necessary to develop a
more sensitive blood biomarker that account for long-
term, low-dose exposure to OPP.
There is much evidence relating low-level and prolonged
OPP exposure with cognitive performance deterioration.
Scientific literature reporting the effects of long-term ex-
posure to OPP in cognitive processes strongly indicates
that the impairment of cognitive or neurological pro-
cesses correlates with the time of exposure to OPP [1,2].
Rohlman and collaborators [8] indicate that the appear-
ance of this disorder does not always correlate with an
inhibited cholinesterase activity, suggesting that the ac-
tion of OPP depends on the type and burden of pesticides
to which people are exposed. At the same time, it is im-
portant to mention that most studies have measured bio-
markers and neuropsychological performance only once,
not considering different fumigation seasons that allow for
the possibility of reversibility on neuropsychological per-
formance [9,10]. Methodological weaknesses of previous
studies are related to examining different occupational
groups with different levels and routes of exposure, having
different time periods, low samples, and other epidemio-
logical constraints that limit variables of exposure and
health effects, among others [11]. Furthermore, existing
biomarkers are not that sensitive and do not allow for
measuring chronic exposure nor chronic effects [8].
Acylpeptide hydrolase (ACPH) is a non-cholinesterase
target of OPP that seems to be involved in the effects of
these molecules have on cognitive processes [12]. ACPH,
also known as acylamino-acid releasing enzyme or acyla-
minoacyl peptidase, is a homomeric tetramer that be-
longs to the family of prolyl-oligopeptidase of the serine
hydrolases [13] and catalyzes the hydrolysis of several
peptides possessing an acylated N-terminal amino acid to
generate an acylated amino acid and a free N-terminal
peptide [14,15]. It has also been described as a truncated
form of the enzyme having endopeptidase activity [16]. In
mammals, ACPH acts in coordination with proteasome to
clear cytotoxic denatured proteins from cells [17,18].
Strong inhibition of ACPH activity leads to apoptosis [19],
and deletions in the gene encoding ACPH leading to defi-
ciencies of this enzyme have been observed in renal and
small-cell lung carcinomas [20,21]. Regarding the role of
ACPH in the nervous system, it is known that ACPH is in-
volved in the moderation of synaptic activity [22] and can
be found localized in pre-synaptic compartments of the
rat telencephalon [23]. Interestingly, it has been reported
that ACPH can degrade monomers, dimers and trimers of
the Aβ1–40 peptide [24,25].
Richards and collaborators reported that some OPP
such as chlorpyrifos-methyl oxon, dichlorvos, and diiso-
propyl fluorophosphate (DFP) exhibit a higher affinity
toward ACPH compared to AChE. Specifically, dichlor-
vos and DFP showed an increased affinity of 6.6 - 10.6
fold toward ACPH with respect to AChE [26]. On the
other hand, it has been demonstrated in animal models
that the inhibition of ACPH by the OPP dichlorvos had
biphasic effects in the cellular mechanisms responsible
for learning and memory, while low doses of dichlorvos
had positive effects on synaptic plasticity processes, and
high doses or prolonged exposure times have the oppos-
ite effect and are neurotoxic [12]. In spite of this, it has
been described that chlorpiryfos-oxon, diazoxon, para-
oxon and mipafox, among other organophosphate com-
pounds, inhibit ACPH as well as AChE activity from
erythrocytes. This lack of specificity is compensated for
by the persistence of inhibition toward ACPH activity
(more than four days) compared with the inhibition of
erythrocyte AChE activity or plasma ChE activity, which
has a half- life of 11 days [27,28].
These findings support the notion of the usefulness of
erythrocyte ACPH activity as having high sensibility and
being a reliable biomarker for monitoring chronic expos-
ure to OPP [12] associated with cognitive deterioration.
Aims and objectives
The main purpose of this study is to develop measure-
ment of ACPH activity as novel erythrocyte biomarkers
that will help identify early diagnosis of chronic exposure
to OPP associated with neuropsychological impairment.
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The study design addresses some of the methodological
concerns described by previous research [10,11,29]: the
evaluation of more than one control group and measuring
biomarker activity along with neuropsychological per-
formance at different moments during the spraying season
(before, during and after spraying with pesticides).
Specific objectives
▪ To obtain activity profiles of the two blood enzyme
biomarkers commonly measured. We used AChE and
ChE and the new biomarker, ACPH, in three cohorts
with different levels of exposure to OPP: occupational,
environmental and with no known exposure.
▪ To obtain the neuropsychological performance
profiles in the three cohorts described above and to
assess the risk of cognitive impairment in these
populations.
▪ To correlate the enzymatic activities of each of the
three biomarkers with the cognitive status in the
cohorts described above with different levels of OPP
exposure.
▪ To analyse changes in the enzyme activities and/or in
cognitive performances within occupationally and
environmentally exposed cohorts that are dependent
upon the fumigation period (before, during and after
fumigation).
▪ To establish if ACPH activity is a suitable biomarker
of long-term exposure to OPP associated with cognitive
deterioration.
Methods/Design
Settings and target population
The study was conducted between the fall of 2011 and the
fall of 2014 in urban and rural locations of Coquimbo Re-
gion, in northern Chile. People from two urban locations
(the cities of Coquimbo and La Serena) and four rural dis-
tricts (La Higuera, Paihuano, Vicuña and Monte Patria)
were recruited. The main agricultural activity is located at
Paihuano, Vicuña and Monte Patria districts and is related
to grapes and citrus farming. To be included in the study,
the subjects had to fit the following criteria: between 18
and 50 years old, right-handed and without diagnosis of
neurological or psychiatric illness. Three population
groups were considered: Group I (External Control) in-
dividuals without environmental or occupational expos-
ure to OPP and living in coastal locations; Group II
(Internal Control) living in rural locations near farming
activities and probably under environmental exposure;
and Group III (Occupational Control) people occupa-
tionally exposed to pesticides and composed of agricul-
tural labourers living in rural areas in direct contact
with pesticides for more than 5 years. Within this third
group there were blenders, fumigators, tractor drivers,
supervisors, collectors and packing workers. Also, to be
included in this group, individuals must never have suf-
fered acute intoxication due to OPP.
For all recruited individuals across the study, a base-
line neuropsychological interview was done and a blood
sample was taken. All procedures were accomplished in
a mobile laboratory (an adapted Peugeot Boxer van, sta-
tioned permanently at the farms). All evaluations were
carried out annually in three time frames for the occupa-
tionally exposed group (before, during and after fumiga-
tion period); in two time frames for internal control
group (before and during fumigation) and a single time
frame for the external controls. Exclusion criteria were:
left-handedness, diagnosis of medical or psychiatric dis-
ease or disability and use of psychopharmacologic meds.
For details, see Figure 1.
Ethical considerations
Ethical approval for the study was obtained from the Re-
search Ethics Committee of the Universidad Católica del
Norte (The Catholic University of the North, in Coquimbo,
Chile), dated August 25, 2014. Informed consent was ex-
plained to voluntary participants and signed by them before
their recruitment.
Power and sample size estimation
Two main objectives of the study were considered when
calculating the number of participants to be recruited: a
prevalence study (measuring enzymes activity and
neuropsychological performance) and case control study
(assessing ACPH as diagnostic test). The size of the oc-
cupationally exposed population in Coquimbo Region is
14,000 workers according to Ministry of Agriculture
(2008) [30]. Considering that 10% of those workers have
tasks involving direct use of pesticides (mixers, blenders,
applicators), with a 95% exposure rate, a minimal sample
size of 70 people was considered to be adequate for the
prevalence study with 5% margin of error [31]. Secondly,
for assessing the diagnostic test, the sample size was cal-
culated based on the following equation [32]:
n ¼ Zα 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2p 1−pð Þp þ Zβ 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p1 1−p1ð Þ þ p2 1−p2ð Þ
p 2
p1−p2ð Þ2
This considers the diagnostic test assessment as a case–
control study; the “cases” being those people having neuro-
psychological impairment, and the “controls” being those
people considered “normal” in their neuropsychological
performance. Occupationally exposed people were ex-
pected to have less ACPH activity than non-occupationally
exposed people. Assuming that the ACPH activity is ori-
ented to have high sensitivity (0.999) for non-exposed
people and have 60% specificity for non-exposed people,
the “n” for this scenario would be 77 individuals. Finally,
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considering that between 20 to 30 per cent of the volun-
teers could be lost to yearly follow-up, the minimum
number of study participants recruited were 100 people
per group.
Identification and recruitment of participants
Several meetings were held in different locations, where
the field team explained the project and collected personal
contact information from potential participants. Trained
medical students employed a short questionnaire in order
to eliminate people who did not fill full the enrolment cri-
teria. The main questionnaire was then applied to those
who met the requirements. A code was given to each par-
ticipant, which was used for identification in the question-
naire, labelling blood samples and for neuropsychological
tests results. The neuropsychological evaluation and blood
samples were taken at the same time on a fixed date in
agreement with the volunteers.
Biomarkers evaluation
In blood samples, the levels of three enzymes related
to OPP exposure in the three population groups were
assessed. The evaluations were done in the field, in a
mobile laboratory especially equipped for this purpose.
The enzymes considered were: plasmatic AChE, ChE
and ACPH; and were measured as explained in the “Set-
ting and Target Population” section.
Blood samples collection, storage, and transportation
A robust sampling and tracking system has was imple-
mented to ensure both proper blood sample collection
and survey data from each volunteer. Volunteers signed
the consent form at the beginning of the process, after a
detailed explanation of the project. Blood samples were
collected by venepuncture in EDTA anticoagulant vacu-
tainers, coded using a unique sample identification code
and processed daily within 12 hours, keeping them at 4°C
inside the mobile laboratory. Processing samples in the
field consisted of separating plasma from cells by centrifu-
gation (10 min, 3000 rpm, 4°C), after which the cell frac-
tion was washed twice with cold PBS 1X and finally, each
fraction (cells and plasma) was aliquot sequenced in three
cryovial tubes labelled and frozen using liquid nitrogen.
During transportation, the samples remained at −80°C
Figure 1 Methodology chart: selected population groups, timeline evaluation and variables to measure.
Ramírez-Santana et al. BMC Public Health  (2015) 15:116 Page 4 of 9
until final analysis. The paramedic transporting and trans-
ferring all biological material to the technician kept a
registration log of all collected specimens. Once in the lab,
the technician checked and stored the samples.
Laboratory analysis
One aliquot of each faction was thawed before enzymatic
measurement. All determinations were done in triplicate
based on Ellman et al., (1961) method [33]. We used the
spectrophotometer Specord type 205 (AnalitikaJena).
Plasmatic Cholinesterase (ChE) was measured directly
using non-diluted plasma. Enzymatic activity was nor-
malized using the protein content in the assay, protein
content was determined by the bicinchoninic acid method
[34] and enzymatic activity from each fraction was ex-
pressed as mean ± SD.
Erythrocytic Cholinesterase (AChE): To obtain the
protein from broken erythrocytes, cells were lysed using
dythiothreitol (1 mM). After centrifuge (10000 rpm, 30 min,
4°C) the supernatant was separated from the pellet and
kept on ice to ACHP measurement. The pellet was
washed once with cold phosphate buffer (0.05 M) and
then measured in a reaction assay mixture (1.037 mL),
which consisted of 5.5′-dithio-bis-2-nitrobenzoic acid
(DTNB [0.241 mM]), acetylthiocholine (A-s-choline
[0.029 mM]), disodium phosphate buffer (Na2HPO4
[0.31 mM]) and potassium phosphate buffer (KH2PO4
[0.023 mM]). Hydrolysis rate of acetylthiocholine is
followed as indicated above (see plasma cholinesterase).
Acyl peptide hydrolase (ACPH): The measurement
was determined using Tris–HCl (7.4 pH [100 mM] with
DTT [1 mM]. The reagent mixture (1.020 mL) consisted
of N-acetyl-L-alanine p-nitroaniline (AANA [3,9 mM]),
Tris–HCl buffer (7.4 pH [95.59 mM], dythiothreitol (DTT
[0.96 mM]) and dymethylsulfoxide (DMSO [275.88 mM].
Hydrolysis rate of AANA was then followed spectrophoto-
metrically by the formation of p-nitroanilide (ε410 =
8800 M−1 cm−1) and measured at 405 nm, at 37°C during
40 min. The enzymatic activity was normalized to the
haemoglobin content in the original blood sample vol-
ume. Haemoglobin was then measured using the cyan-
methaemoglobin method [35]. Briefly, blood samples
were mixed with a solution containing ferricyanide and
cyanide. Haemoglobin changing to cyan-methaemoglobin
was then measured at 520 nm.
Quality control
In order to validate the replicability of our results, the
National Institute of Public Health (Santiago, Chile)
supported the quality control for plasmatic and erythro-
cytic cholinesterase. A random subset of samples were
sent to the laboratory of Occupational Toxicology at the
Department of Occupational Health in the Institute of
Public Health, where plasmatic and erythrocytic cholinesterase
activities were determined according to Ellman’s method.
The resulting data obtained at the Institute of Public
Health were matched to the results of the same samples
obtained in our laboratory and statistical comparison per-
formed. This procedure was done for each of the cohorts
being evaluated.
Methods for neuropsychological evaluation
In order to diagnose cognitive impairment, a Speech Ther-
apist performed a psychological interviews and neuro-
psychological battery of tests for each volunteer. This
battery covered three areas: cognitive functions, mood and
psychomotor activity. We considered these three areas be-
cause the accumulation of acetylcholine in the synaptic
cleft continuously stimulates the cholinergic synapses,
triggering diverse symptoms in the neuro-conduct, cogni-
tive and neuro-muscle areas. Table 1 shows the different
cognitive functions and the tests used for their evaluation
[36-39]. The time frame for a complete and individual
evaluation was about three hours. The effects of fatigue on
level of cognitive performance was addressed by beginning
each evaluation with those tests most sensitive to fatigue,
such as attention span, time of reaction and speed of
process [40,41]. Additionally, a rest interval was included
during the process.
Table 1 Cognitive functions and associated tests
Function Neuropsychological tests
Memory Rey auditory verbal learning (memory phase)
Benton visual retention (4 subtest)
Logic memory (WMS) (2 subtest)
Serial digits learning
Constructive Praxis Rey complex figure (copy phase)
WAIS Cubes




Battery for frontal evaluation FAB





Motor Function Pardue pegboard test (4 subtest)
MOART reaction and movement time
panel (2 subtest)
Finger tapping test (2 subtest)
Mood status Beck BDI-II depression inventory
Hamilton anxiety scale
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The evaluations were all performed by a Speech Therap-
ist trained and supervised by a board certified neuropsych-
ologist; in this way, inter-assessor’s bias is eliminated. All
procedures are carried out in the mobile laboratory. To
avoid a learning gap effect, tests that had a low learning
component were selected and carried out at intervals of at
least two months. In relation to assessment instruments,
these were selected according to the following criteria: age
of participants, reading and writing skills and absence of
severe sensory deficits. It is necessary to indicate that,
given the number of tests being applied and the time it
took, we evaluated only two to three individuals a day. A
baseline manual for measuring level of performance was
used for each original set of tests, and scores of the ex-
posed populations compared with scores of the control
population. We calculated neuropsychological results clus-
tered by area (cognitive functions: memory, attention
span, constructive praxis; executive functions: mood and
psychomotor activity) and by the average score given by
test for each area. A unique final score will be calculated
for each individual and evaluation time.
Exposure characterization
Trained medical students conducted interviews using a
questionnaire to assess personal, medical, social and
occupational conditions. This questionnaire covered a
broad spectrum of information in order to avoid misper-
ceptions, because most people involved in the study are
farmers or fishermen with very basic educational levels.
The different topics in the inquiry included: personal
data (gender, age, occupation, address and years of study);
consumption habits (tobacco, alcohol, drugs, medicines);
family and personal medical history (including obstetric
history for women, e.g. miscarriage or reproductive prob-
lems); occupational history, time of exposure to pesticides
(years working and number of workdays per season each
year); knowledge, training and use of safety measures at
work.
In order to correlate the level of exposure with the
neuropsychological and enzymes outcomes, a single
variable of occupational exposure was developed that
considered the number of years living in the farming
area (for internal control). For the workers, the variable
was constructed using years living in farming area and
years working with pesticides. Because agricultural work
is seasonal, workers are not always in contact with pesti-
cides the entire year. Therefore, the amount of working
years was corrected by estimating the number of days
actually worked using pesticides during a calendar year.
In addition, those “adjusted” years were amplified by an
“occupational exposure factor” of three fold; based on pub-
lications that show Odds Ratio 3 to 7.9 of self -reported
symptoms on workers after using pesticides in relation to
controls in similar settings [42,43]. The equation that re-
lates these parameters is called Days of Adjusted Life Long
Occupational Exposure to Pesticides (ALLOEP) and is de-
scribed as follows:
ALLOEP ¼ ð years living in agricultural area  365ð Þ
þ ðn years  n days=year; working=
contact pesticides  3ÞÞ = 365
Of course, several factors could affect the absorption
of pesticides in workers and therefore exposure level
would be moderated. Information about hazards, proper
handling, use of protective equipment and safety mea-
sures are proven to be effective in reducing exposure in
percentages from 2% up to 77%, depending on the pro-
tective equipment used [44]. The possibility of including
a moderation factor to the exposure variable ALLOEP
will be explored [44-47]. Refer to Table 2 to for details
about variable description and factors utilized to build
indicators measuring exposure.
Reporting participants and feedback
Information is being distributed to stakeholders about
the progress of the project on a regular basis. Individual
lab results on enzymes activity and neuropsychological
evaluation will be given to participants at the end of the
project by the Project Director as a summary, instead of
informing each individual test result from the large bat-
tery of tests.
Epidemiologic data analysis and statistical analysis
Statistical analysis will be done in SPSS. Several steps
will be followed for the data analysis, given the different
specific objectives of the study.
1. To investigate the trends of the three biomarkers in
each of the population groups: simple descriptions
of the enzymatic activity with the support of
Table 2 Variable description and factors utilized to build indicators measuring exposure
Exposure Variable description Variable construction
Environmental Number of days living in farming area Number of years living in farming area times 365 (days per year)
Occupational Life-long occupational exposure (days) Number of years living in farming area times 365 (days per year) +
(number of years working in contact with pesticides times number
of days working per year*)
“Adjusted Life-long Exposure to Pesticides” - ALLOEP score The result from the upper row amplified by 3-fold increase of exposure
(*) Number of months per year working in contact with pesticides, according to information declared in the questionnaire for seasonal workers.
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scattering graphs are being done for each of the
biomarkers in every population group (occupationally
exposed, internal control group and external control),
and for each one of the fumigation periods
considered. ANOVA tests are being utilized to detect
significant differences in the average of enzymatic
activity between groups and between fumigation
periods among exposed (occupational and
environmental) groups. Differences on enzymatic
activities within each individual will be assessed when
volunteers have more than one measurement.
2. To assess risk of neuropsychological weakening in
the three population groups: according to standard
test scores, “normal” and “under normal” individuals
were selected. Taking the external control group as a
baseline to compare the performances of
neuropsychological evaluation, Odds Ratio (OR) are
being calculated for each of the exposed population
groups (environmental and occupational exposure)
and for the different fumigation seasons. In order to
avoid confounding affected by age and level of
education, OR are stratified by age, level of
education and alcohol consumption. Chi square and
Confidence Interval are being calculated for each
OR in order to detect significance and power.
Mantel and Heanzel correction will be used when
necessary.
3. To correlate enzymatic activity of the three
biomarkers with level of exposure: to reach this
objective with the three population groups and
different fumigation periods, we are using synthesis
for exposure level in a single variable (ALLOEP).
4. To correlate enzymatic activity of the three
biomarkers with neuropsychological performance: in
the three population groups and different fumigation
periods, test scores are being correlated with
enzymatic activity for the three biomarkers.
5. To assess the performance of the activity of ACPH
as a diagnostic test of prolonged exposure to OPP:
ROC curves are being developed utilizing
performance result in the battery of tests as gold
standard. The case definition criteria extracted from
the performance in the battery of tests are taken from
the scale of each test given by the test provider.
The entire population of participants evaluated in base-
line condition (pre-fumigation) were selected as “cases”
and “controls” according to the “case definition criteria”;
the “cases” being people with poor test performance and
the “controls” being those people with normal test
performance.
The contribution of enzymes or any other variables in
predicting a case are being assessed using logistic regression
model. Inclusion of other data mining techniques for
exploring predictive models is currently being explored
(neuronal networks and decision tree).
Discussion
One of the strengths of this study is the assessment of
more than one control group for occupational exposure,
which includes the possibility of evaluating effects of en-
vironmental and occupational exposures. Inclusion and
exclusion criteria improve design by avoiding selection
bias and confusion (age; urban or rural social context;
no neuropsychological illness, trauma and/or medica-
tion; right-handedness; no known pesticide intoxication).
Additionally, all outcomes are being measured on baseline
and during fumigation period, permitting the assessment
of changes on enzymatic activity and neuropsychological
effects of pesticides among individuals, populations, and
fumigation periods. In the exposed group it is possible to
assess whether biomarkers return to baseline within two
to three months after cessation of exposure. Regarding the
neuropsychological outcome, effects of aging will be
avoided by selecting people from 18 to 50 years old; sev-
eral tests will be performed and several cognitive areas
explored; and we will increase the specificity of the diagnos-
tic tool, according to suggestions described in literature
[48]. Keep in mind that neuropsychological evaluation
will be used as gold standard for diagnosis of cognitive
impairment.
An acknowledged weakness of the study is that no re-
sult may be related to a specific chemical compound be-
cause it is not possible to identify the specific pesticides
being used by the workers or determine their metabo-
lites in either biological or environmental specimens.
According to the literature [49,50], we assume that or-
ganophosphate and carbamates are the most used pesti-
cides in the region, according to type of crop (grapes
and citrus fruits) and the season of the evaluation. The
study did not evaluate retired workers because the aim
was to assess biomarker in workers, and not in perform-
ing consequences or causality of exposure; nevertheless,
this could be a complementary result.
This study design was implemented during the 2011–
2013 sample collection, neuropsychological evaluation
and data collection process. So far, seasonal recruitment
of participants has been a success given the difficulties
found in the work place, which have been sorted-out
during subsequent years by our experience gained and
contacts made. The support of the municipalities and
farmers’ associations has been important to avoid prob-
lems in the field. Based on our experience over these
past few years, mobile laboratory use has been a success,
the application of the neuropsychological evaluation of
the tests battery by a single professional has been im-
portant in order to avoid bias and quality control of the
laboratory procedures has been adequate as well.
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